Mindblown: a blog about philosophy.

By Carolina Mandl NEW YORK (Reuters) – Some big investors showed increased appetite for weight-loss drug makers in the third quarter, piling in to shares of Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) amid growing demand for their product, securities filings showed on Tuesday. Shares of both companies have soared this year as Novo Nordisk’s […]

By Carolina Mandl NEW YORK (Reuters) – Some big investors showed increased appetite for weight-loss drug makers in the third quarter, piling in to shares of Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) amid growing demand for their product, securities filings showed on Tuesday. Shares of both companies have soared this year as Novo Nordisk’s […]

By Carolina Mandl NEW YORK (Reuters) – Some big investors showed increased appetite for weight-loss drug makers in the third quarter, piling in to shares of Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) amid growing demand for their product, securities filings showed on Tuesday. Shares of both companies have soared this year as Novo Nordisk’s […]

By Carolina Mandl NEW YORK (Reuters) – Some big investors showed increased appetite for weight-loss drug makers in the third quarter, piling in to shares of Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) amid growing demand for their product, securities filings showed on Tuesday. Shares of both companies have soared this year as Novo Nordisk’s […]

By Carolina Mandl NEW YORK (Reuters) – Some big investors showed increased appetite for weight-loss drug makers in the third quarter, piling in to shares of Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) amid growing demand for their product, securities filings showed on Tuesday. Shares of both companies have soared this year as Novo Nordisk’s […]

By Carolina Mandl NEW YORK (Reuters) – Some big investors showed increased appetite for weight-loss drug makers in the third quarter, piling in to shares of Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) amid growing demand for their product, securities filings showed on Tuesday. Shares of both companies have soared this year as Novo Nordisk’s […]

By Carolina Mandl NEW YORK (Reuters) – Some big investors showed increased appetite for weight-loss drug makers in the third quarter, piling in to shares of Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) amid growing demand for their product, securities filings showed on Tuesday. Shares of both companies have soared this year as Novo Nordisk’s […]

By Carolina Mandl NEW YORK (Reuters) – Some big investors showed increased appetite for weight-loss drug makers in the third quarter, piling in to shares of Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) amid growing demand for their product, securities filings showed on Tuesday. Shares of both companies have soared this year as Novo Nordisk’s […]

HOUSTON (Reuters) – A planned overhaul of the gasoline-producing fluidic catalytic cracker (FCC) at TotalEnergies’ 238,000 barrel-per-day (bpd) Port Arthur, Texas refinery is expected to continue into late November, said people familiar with plant operations. The 76,000-bpd gasoline-producing fluidic catalytic cracker-2 was shut on Aug. 23 for a planned overhaul. “We do not comment on […]

HOUSTON (Reuters) – A planned overhaul of the gasoline-producing fluidic catalytic cracker (FCC) at TotalEnergies’ 238,000 barrel-per-day (bpd) Port Arthur, Texas refinery is expected to continue into late November, said people familiar with plant operations. The 76,000-bpd gasoline-producing fluidic catalytic cracker-2 was shut on Aug. 23 for a planned overhaul. “We do not comment on […]